Capricor Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| CAPR | SLDB | SRPT | RGNX | FDMT | RCKT | |
|---|---|---|---|---|---|---|
| Market cap | 434.30M | 719.48M | 1.84B | 512.92M | 718.17M | 272.24M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -5.1 | -3.9 | 7.3 | -2.6 | -3.2 | -1.9 |
| Price/book | 1.8 | 1.9 | 1.2 | 5.9 | 1.8 | 0.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +16.52% | +14.31% | −18.72% | −28.84% | +37.85% | −26.22% |
| Today | −4.60% | −2.33% | −2.30% | −3.72% | −2.48% | −3.13% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All CAPR news ›Capricor Therapeutics Tokenized Stock (Ondo) to Russian Ruble Price Today | Live CAPRon to RUB Converter & Exchange Rate | CryptoRank.io
Capricor Therapeutics Tokenized Stock (Ondo) CryptoRank Capricor Therapeutics Tokenized Stock (Ondo)CAPRon/RUB Price CAPRon to RUB Price Chart A marketplace of trading strategies, and tools 7-day price history of Capricor Therapeutics…
Analysts Conflicted on These Healthcare Names: Capricor Therapeutics (CAPR), Alector (ALEC) and Irhythm Technologies (IRTC)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Capricor Therapeutics (CAPR), Alector (ALEC) and Irhythm Technologies (IRTC). In a report released today, Joseph Pantginis from H.C.…
Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy Transcript
Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data and Deramiocel Update for Duchenne Muscular Dystrophy October 7, 2026 4:00 PM... Capricor Therapeutics, Inc. (CAPR) Discusses HOPE-3 Open-Label Extension Data…
Bronstein, Gewirtz & Grossman LLC Urges Netcapital Inc. Investors to Act: Class Action Filed Alleging Investor Harm
lincolnjournal.com Javascript is required for you to be able to read premium content. Please enable it in your browser settings. Sorry, an error occurred. Account processing issue - the email address may already exist Must be at least 8…
FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law
FHTX Investors with $100,000 in Losses Have Opportunity to Join F The National Law Review FHTX Investors with $100,000 in Losses Have Opportunity to Join Foghorn Therapeutics Inc. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS…
Entrada Therapeutics: Weak Dystrophin Data May Be Creating A Buying Opportunity
Entrada Therapeutics (ENTR) Buy call: $8.50 fair value (~52% upside). Valuation is anchored by risk-adjusted pipeline estimates. See more details here. - Entrada Therapeutics is rated Buy with a $8.50 fair value, offering ~52% upside from…
NCPL Investors Have Opportunity to Lead Netcapital Inc. Securities Fraud Lawsuit Filed by The Rosen Law Firm
Local3News.com 9, 2026 /PRNewswire/ --Why: Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of securities of Netcapital Inc (NASDAQ: NCPL) between December 15, 2021…
Investor Alert: Robbins LLP Informs Investors of The Chemours Company Class Action Lawsuit
The complaint alleges that Chemours materially overstated market demand for its products. Investors who purchased Chemours securities during the Class Period and suffered significant losses should contact Robbins LLP for information about…
Capricor Therapeutics Tokenized Stock (Ondo) Analytics: Price Dynamics, Quarterly Returns, and Annual Price Changes in USD | CryptoRank.io
Capricor Therapeutics Tokenized Stock (Ondo) Analytics CryptoRank Capricor Therapeutics Tokenized Stock (Ondo) Analytics Capricor Therapeutics Tokenized Stock (Ondo) Quarterly Returns (USD) Capricor Therapeutics Tokenized Stock (Ondo)…
Investors accuse Netcapital of inflating revenue through sham deals
A NASDAQ-listed crowdfunding portal faces a class action alleging its leadership fabricated nearly $14 million in consulting revenue over roughly three years. The complaint, filed October 8 in US District Court in Massachusetts, names…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
prnewswire.com17
-
newsfilecorp.com11
-
natlawreview.com5
-
tradingview.com5
-
tigersroar.com4
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 102 articles, not a forecast.